Making the best of an inflationary environment

With the latest inflation figures higher than expected this week, the RBA has warned it does not foresee any interest rate cuts until the end of 2024.

Telix testing shows efficacy of anti-prostate cancer therapy

Telix Pharmaceuticals Ltd has picked up some positive results in testing of its anti-prostate cancer therapy.

Daily ASX Market Update: Health pushes shares into gain terrain - May 31, 2024

The ASX200 is trading up around 0.55%With strong performances from major medical companies, the healthcare sector is leading gains, up 1.2%, Discretionary follows, up nearly a per cent.IT is the only sector to fall into the red, down a quarter of a per cent.Telix Pharmaceuticals PharmAust Hazer G...

Thor reports 200% increase in tungsten at NT's Molyhil

Thor Energy Plc has reported a 200% increase in contained tungsten in the measured category at its Molyhil project in the Northern Territory.

Hazer Group and POSCO team up to look at low carbon steel

Hazer Group (ASX:HZR) has signed an MoU with Korea's POSCO to investigate low carbon steel synergies using the former's tech.

Talga shows expansion options for Sweden's Vittangi graphite project

Talga Group Ltd has completed an expansion study on mining at its Vittangi Graphite Project in Sweden's northeast.

Peak shale oil and fracking activity drives demand for Eden's Optiblend in the USA

OptiBlend says demand for its diesel generators in the USA and India is rebounding after a tepid past 9 months as fracking, hits a peak.

FDA greenlights Avita's RECELL GO skin transplant cell harvesting device

Avita Medical (ASX:AVH) has announced the US FDA has issued a premarket approval for its RECELL GO skin cell harvesting device.

Spacetalk makes European Market Reentry with Elisa

Spacetalk is re-entering the European market in partnership with Elisa in Finland as part of an expansion strategy.